In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death

In situ normothermic regional perfusion (NRP) and ex situ normothermic machine perfusion (NMP) aim to improve the outcomes of liver transplantation (LT) using controlled donation after circulatory death (cDCD). NRP and NMP have not yet been compared directly. In this international observational stud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:LIVER TRANSPLANTATION 2022-11, Vol.28 (11), p.1716-1725
Hauptverfasser: Mohkam, Kayvan, Nasralla, David, Mergental, Hynek, Muller, Xavier, Butler, Andrew, Jassem, Wayel, Imber, Charles, Monbaliu, Diethard, Perera, M. Thamara P.R, Laing, Richard W, Garcia-Valdecasas, Juan Carlos, Paul, Andreas, Dondero, Federica, Cauchy, Francois, Savier, Eric, Scatton, Olivier, Robin, Fabien, Sulpice, Laurent, Bucur, Petru, Salame, Ephrem, Pittau, Gabriella, Allard, Marc-Antoine, Pradat, Pierre, Rossignol, Guillaume, Mabrut, Jean-Yves, Ploeg, Rutger J, Friend, Peter J, Mirza, Darius F, Lesurtel, Mickael
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1725
container_issue 11
container_start_page 1716
container_title LIVER TRANSPLANTATION
container_volume 28
creator Mohkam, Kayvan
Nasralla, David
Mergental, Hynek
Muller, Xavier
Butler, Andrew
Jassem, Wayel
Imber, Charles
Monbaliu, Diethard
Perera, M. Thamara P.R
Laing, Richard W
Garcia-Valdecasas, Juan Carlos
Paul, Andreas
Dondero, Federica
Cauchy, Francois
Savier, Eric
Scatton, Olivier
Robin, Fabien
Sulpice, Laurent
Bucur, Petru
Salame, Ephrem
Pittau, Gabriella
Allard, Marc-Antoine
Pradat, Pierre
Rossignol, Guillaume
Mabrut, Jean-Yves
Ploeg, Rutger J
Friend, Peter J
Mirza, Darius F
Lesurtel, Mickael
description In situ normothermic regional perfusion (NRP) and ex situ normothermic machine perfusion (NMP) aim to improve the outcomes of liver transplantation (LT) using controlled donation after circulatory death (cDCD). NRP and NMP have not yet been compared directly. In this international observational study, outcomes of LT performed between 2015 and 2019 for organs procured from cDCD donors subjected to NRP or NMP commenced at the donor center were compared using propensity score matching (PSM). Of the 224 cDCD donations in the NRP cohort that proceeded to asystole, 193 livers were procured, resulting in 157 transplants. In the NMP cohort, perfusion was commenced in all 40 cases and resulted in 34 transplants (use rates: 70% vs. 85% [p = 0.052], respectively). After PSM, 34 NMP liver recipients were matched with 68 NRP liver recipients. The two cohorts were similar for donor functional warm ischemia time (21 min after NRP vs. 20 min after NMP; p = 0.17), UK-Donation After Circulatory Death risk score (5 vs. 5 points; p = 0.38), and laboratory Model for End-Stage Liver Disease scores (12 vs. 12 points; p = 0.83). The incidence of nonanastomotic biliary strictures (1.5% vs. 2.9%; p > 0.99), early allograft dysfunction (20.6% vs. 8.8%; p = 0.13), and 30-day graft loss (4.4% vs. 8.8%; p = 0.40) were similar, although peak posttransplant aspartate aminotransferase levels were higher in the NRP cohort (872 vs. 344 IU/L; p 
format Article
fullrecord <record><control><sourceid>kuleuven</sourceid><recordid>TN_cdi_kuleuven_dspace_20_500_12942_697692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20_500_12942_697692</sourcerecordid><originalsourceid>FETCH-kuleuven_dspace_20_500_12942_6976923</originalsourceid><addsrcrecordid>eNqVjMFOwzAQRH0AqaX0H_aMVOS4TaqcKxDcuVsrZ9OYOnbkXVflP_hgAuLAgQOcZkbzZq7UsqrNftPsmnqhbphfta6qutVL9f4cgb0UiCmPSQbKo3eQ6ehTxAAT5b7w7OFMmQsDXX7BR3SDj_SD9hGCnycgGSNPAaOgfBZ9TiN08_dXwl5mxvnsSkBJ-Q06Qhlu1XWPgWn9rSt19_jwcnjanEqgcqZoO57QkTXa1lrbyrQ7Y5t237Rmu1L3f4atXGT7r_cPaidraQ</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death</title><source>Lirias (KU Leuven Association)</source><source>Access via Wiley Online Library</source><source>Alma/SFX Local Collection</source><creator>Mohkam, Kayvan ; Nasralla, David ; Mergental, Hynek ; Muller, Xavier ; Butler, Andrew ; Jassem, Wayel ; Imber, Charles ; Monbaliu, Diethard ; Perera, M. Thamara P.R ; Laing, Richard W ; Garcia-Valdecasas, Juan Carlos ; Paul, Andreas ; Dondero, Federica ; Cauchy, Francois ; Savier, Eric ; Scatton, Olivier ; Robin, Fabien ; Sulpice, Laurent ; Bucur, Petru ; Salame, Ephrem ; Pittau, Gabriella ; Allard, Marc-Antoine ; Pradat, Pierre ; Rossignol, Guillaume ; Mabrut, Jean-Yves ; Ploeg, Rutger J ; Friend, Peter J ; Mirza, Darius F ; Lesurtel, Mickael</creator><creatorcontrib>Mohkam, Kayvan ; Nasralla, David ; Mergental, Hynek ; Muller, Xavier ; Butler, Andrew ; Jassem, Wayel ; Imber, Charles ; Monbaliu, Diethard ; Perera, M. Thamara P.R ; Laing, Richard W ; Garcia-Valdecasas, Juan Carlos ; Paul, Andreas ; Dondero, Federica ; Cauchy, Francois ; Savier, Eric ; Scatton, Olivier ; Robin, Fabien ; Sulpice, Laurent ; Bucur, Petru ; Salame, Ephrem ; Pittau, Gabriella ; Allard, Marc-Antoine ; Pradat, Pierre ; Rossignol, Guillaume ; Mabrut, Jean-Yves ; Ploeg, Rutger J ; Friend, Peter J ; Mirza, Darius F ; Lesurtel, Mickael</creatorcontrib><description>In situ normothermic regional perfusion (NRP) and ex situ normothermic machine perfusion (NMP) aim to improve the outcomes of liver transplantation (LT) using controlled donation after circulatory death (cDCD). NRP and NMP have not yet been compared directly. In this international observational study, outcomes of LT performed between 2015 and 2019 for organs procured from cDCD donors subjected to NRP or NMP commenced at the donor center were compared using propensity score matching (PSM). Of the 224 cDCD donations in the NRP cohort that proceeded to asystole, 193 livers were procured, resulting in 157 transplants. In the NMP cohort, perfusion was commenced in all 40 cases and resulted in 34 transplants (use rates: 70% vs. 85% [p = 0.052], respectively). After PSM, 34 NMP liver recipients were matched with 68 NRP liver recipients. The two cohorts were similar for donor functional warm ischemia time (21 min after NRP vs. 20 min after NMP; p = 0.17), UK-Donation After Circulatory Death risk score (5 vs. 5 points; p = 0.38), and laboratory Model for End-Stage Liver Disease scores (12 vs. 12 points; p = 0.83). The incidence of nonanastomotic biliary strictures (1.5% vs. 2.9%; p &gt; 0.99), early allograft dysfunction (20.6% vs. 8.8%; p = 0.13), and 30-day graft loss (4.4% vs. 8.8%; p = 0.40) were similar, although peak posttransplant aspartate aminotransferase levels were higher in the NRP cohort (872 vs. 344 IU/L; p &lt; 0.001). NRP livers were more frequently allocated to recipients suffering from hepatocellular carcinoma (HCC; 60.3% vs. 20.6%; p &lt; 0.001). HCC-censored 2-year graft and patient survival rates were 91.5% versus 88.2% (p = 0.52) and 97.9% versus 94.1% (p = 0.25) after NRP and NMP, respectively. Both perfusion techniques achieved similar outcomes and appeared to match benchmarks expected for donation after brain death livers. This study may inform the design of a definitive trial.</description><identifier>ISSN: 1527-6465</identifier><language>eng</language><publisher>LIPPINCOTT WILLIAMS &amp; WILKINS</publisher><ispartof>LIVER TRANSPLANTATION, 2022-11, Vol.28 (11), p.1716-1725</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,315,780,784,27860</link.rule.ids></links><search><creatorcontrib>Mohkam, Kayvan</creatorcontrib><creatorcontrib>Nasralla, David</creatorcontrib><creatorcontrib>Mergental, Hynek</creatorcontrib><creatorcontrib>Muller, Xavier</creatorcontrib><creatorcontrib>Butler, Andrew</creatorcontrib><creatorcontrib>Jassem, Wayel</creatorcontrib><creatorcontrib>Imber, Charles</creatorcontrib><creatorcontrib>Monbaliu, Diethard</creatorcontrib><creatorcontrib>Perera, M. Thamara P.R</creatorcontrib><creatorcontrib>Laing, Richard W</creatorcontrib><creatorcontrib>Garcia-Valdecasas, Juan Carlos</creatorcontrib><creatorcontrib>Paul, Andreas</creatorcontrib><creatorcontrib>Dondero, Federica</creatorcontrib><creatorcontrib>Cauchy, Francois</creatorcontrib><creatorcontrib>Savier, Eric</creatorcontrib><creatorcontrib>Scatton, Olivier</creatorcontrib><creatorcontrib>Robin, Fabien</creatorcontrib><creatorcontrib>Sulpice, Laurent</creatorcontrib><creatorcontrib>Bucur, Petru</creatorcontrib><creatorcontrib>Salame, Ephrem</creatorcontrib><creatorcontrib>Pittau, Gabriella</creatorcontrib><creatorcontrib>Allard, Marc-Antoine</creatorcontrib><creatorcontrib>Pradat, Pierre</creatorcontrib><creatorcontrib>Rossignol, Guillaume</creatorcontrib><creatorcontrib>Mabrut, Jean-Yves</creatorcontrib><creatorcontrib>Ploeg, Rutger J</creatorcontrib><creatorcontrib>Friend, Peter J</creatorcontrib><creatorcontrib>Mirza, Darius F</creatorcontrib><creatorcontrib>Lesurtel, Mickael</creatorcontrib><title>In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death</title><title>LIVER TRANSPLANTATION</title><description>In situ normothermic regional perfusion (NRP) and ex situ normothermic machine perfusion (NMP) aim to improve the outcomes of liver transplantation (LT) using controlled donation after circulatory death (cDCD). NRP and NMP have not yet been compared directly. In this international observational study, outcomes of LT performed between 2015 and 2019 for organs procured from cDCD donors subjected to NRP or NMP commenced at the donor center were compared using propensity score matching (PSM). Of the 224 cDCD donations in the NRP cohort that proceeded to asystole, 193 livers were procured, resulting in 157 transplants. In the NMP cohort, perfusion was commenced in all 40 cases and resulted in 34 transplants (use rates: 70% vs. 85% [p = 0.052], respectively). After PSM, 34 NMP liver recipients were matched with 68 NRP liver recipients. The two cohorts were similar for donor functional warm ischemia time (21 min after NRP vs. 20 min after NMP; p = 0.17), UK-Donation After Circulatory Death risk score (5 vs. 5 points; p = 0.38), and laboratory Model for End-Stage Liver Disease scores (12 vs. 12 points; p = 0.83). The incidence of nonanastomotic biliary strictures (1.5% vs. 2.9%; p &gt; 0.99), early allograft dysfunction (20.6% vs. 8.8%; p = 0.13), and 30-day graft loss (4.4% vs. 8.8%; p = 0.40) were similar, although peak posttransplant aspartate aminotransferase levels were higher in the NRP cohort (872 vs. 344 IU/L; p &lt; 0.001). NRP livers were more frequently allocated to recipients suffering from hepatocellular carcinoma (HCC; 60.3% vs. 20.6%; p &lt; 0.001). HCC-censored 2-year graft and patient survival rates were 91.5% versus 88.2% (p = 0.52) and 97.9% versus 94.1% (p = 0.25) after NRP and NMP, respectively. Both perfusion techniques achieved similar outcomes and appeared to match benchmarks expected for donation after brain death livers. This study may inform the design of a definitive trial.</description><issn>1527-6465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>FZOIL</sourceid><recordid>eNqVjMFOwzAQRH0AqaX0H_aMVOS4TaqcKxDcuVsrZ9OYOnbkXVflP_hgAuLAgQOcZkbzZq7UsqrNftPsmnqhbphfta6qutVL9f4cgb0UiCmPSQbKo3eQ6ehTxAAT5b7w7OFMmQsDXX7BR3SDj_SD9hGCnycgGSNPAaOgfBZ9TiN08_dXwl5mxvnsSkBJ-Q06Qhlu1XWPgWn9rSt19_jwcnjanEqgcqZoO57QkTXa1lrbyrQ7Y5t237Rmu1L3f4atXGT7r_cPaidraQ</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Mohkam, Kayvan</creator><creator>Nasralla, David</creator><creator>Mergental, Hynek</creator><creator>Muller, Xavier</creator><creator>Butler, Andrew</creator><creator>Jassem, Wayel</creator><creator>Imber, Charles</creator><creator>Monbaliu, Diethard</creator><creator>Perera, M. Thamara P.R</creator><creator>Laing, Richard W</creator><creator>Garcia-Valdecasas, Juan Carlos</creator><creator>Paul, Andreas</creator><creator>Dondero, Federica</creator><creator>Cauchy, Francois</creator><creator>Savier, Eric</creator><creator>Scatton, Olivier</creator><creator>Robin, Fabien</creator><creator>Sulpice, Laurent</creator><creator>Bucur, Petru</creator><creator>Salame, Ephrem</creator><creator>Pittau, Gabriella</creator><creator>Allard, Marc-Antoine</creator><creator>Pradat, Pierre</creator><creator>Rossignol, Guillaume</creator><creator>Mabrut, Jean-Yves</creator><creator>Ploeg, Rutger J</creator><creator>Friend, Peter J</creator><creator>Mirza, Darius F</creator><creator>Lesurtel, Mickael</creator><general>LIPPINCOTT WILLIAMS &amp; WILKINS</general><scope>FZOIL</scope></search><sort><creationdate>202211</creationdate><title>In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death</title><author>Mohkam, Kayvan ; Nasralla, David ; Mergental, Hynek ; Muller, Xavier ; Butler, Andrew ; Jassem, Wayel ; Imber, Charles ; Monbaliu, Diethard ; Perera, M. Thamara P.R ; Laing, Richard W ; Garcia-Valdecasas, Juan Carlos ; Paul, Andreas ; Dondero, Federica ; Cauchy, Francois ; Savier, Eric ; Scatton, Olivier ; Robin, Fabien ; Sulpice, Laurent ; Bucur, Petru ; Salame, Ephrem ; Pittau, Gabriella ; Allard, Marc-Antoine ; Pradat, Pierre ; Rossignol, Guillaume ; Mabrut, Jean-Yves ; Ploeg, Rutger J ; Friend, Peter J ; Mirza, Darius F ; Lesurtel, Mickael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kuleuven_dspace_20_500_12942_6976923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohkam, Kayvan</creatorcontrib><creatorcontrib>Nasralla, David</creatorcontrib><creatorcontrib>Mergental, Hynek</creatorcontrib><creatorcontrib>Muller, Xavier</creatorcontrib><creatorcontrib>Butler, Andrew</creatorcontrib><creatorcontrib>Jassem, Wayel</creatorcontrib><creatorcontrib>Imber, Charles</creatorcontrib><creatorcontrib>Monbaliu, Diethard</creatorcontrib><creatorcontrib>Perera, M. Thamara P.R</creatorcontrib><creatorcontrib>Laing, Richard W</creatorcontrib><creatorcontrib>Garcia-Valdecasas, Juan Carlos</creatorcontrib><creatorcontrib>Paul, Andreas</creatorcontrib><creatorcontrib>Dondero, Federica</creatorcontrib><creatorcontrib>Cauchy, Francois</creatorcontrib><creatorcontrib>Savier, Eric</creatorcontrib><creatorcontrib>Scatton, Olivier</creatorcontrib><creatorcontrib>Robin, Fabien</creatorcontrib><creatorcontrib>Sulpice, Laurent</creatorcontrib><creatorcontrib>Bucur, Petru</creatorcontrib><creatorcontrib>Salame, Ephrem</creatorcontrib><creatorcontrib>Pittau, Gabriella</creatorcontrib><creatorcontrib>Allard, Marc-Antoine</creatorcontrib><creatorcontrib>Pradat, Pierre</creatorcontrib><creatorcontrib>Rossignol, Guillaume</creatorcontrib><creatorcontrib>Mabrut, Jean-Yves</creatorcontrib><creatorcontrib>Ploeg, Rutger J</creatorcontrib><creatorcontrib>Friend, Peter J</creatorcontrib><creatorcontrib>Mirza, Darius F</creatorcontrib><creatorcontrib>Lesurtel, Mickael</creatorcontrib><collection>Lirias (KU Leuven Association)</collection><jtitle>LIVER TRANSPLANTATION</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohkam, Kayvan</au><au>Nasralla, David</au><au>Mergental, Hynek</au><au>Muller, Xavier</au><au>Butler, Andrew</au><au>Jassem, Wayel</au><au>Imber, Charles</au><au>Monbaliu, Diethard</au><au>Perera, M. Thamara P.R</au><au>Laing, Richard W</au><au>Garcia-Valdecasas, Juan Carlos</au><au>Paul, Andreas</au><au>Dondero, Federica</au><au>Cauchy, Francois</au><au>Savier, Eric</au><au>Scatton, Olivier</au><au>Robin, Fabien</au><au>Sulpice, Laurent</au><au>Bucur, Petru</au><au>Salame, Ephrem</au><au>Pittau, Gabriella</au><au>Allard, Marc-Antoine</au><au>Pradat, Pierre</au><au>Rossignol, Guillaume</au><au>Mabrut, Jean-Yves</au><au>Ploeg, Rutger J</au><au>Friend, Peter J</au><au>Mirza, Darius F</au><au>Lesurtel, Mickael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death</atitle><jtitle>LIVER TRANSPLANTATION</jtitle><date>2022-11</date><risdate>2022</risdate><volume>28</volume><issue>11</issue><spage>1716</spage><epage>1725</epage><pages>1716-1725</pages><issn>1527-6465</issn><abstract>In situ normothermic regional perfusion (NRP) and ex situ normothermic machine perfusion (NMP) aim to improve the outcomes of liver transplantation (LT) using controlled donation after circulatory death (cDCD). NRP and NMP have not yet been compared directly. In this international observational study, outcomes of LT performed between 2015 and 2019 for organs procured from cDCD donors subjected to NRP or NMP commenced at the donor center were compared using propensity score matching (PSM). Of the 224 cDCD donations in the NRP cohort that proceeded to asystole, 193 livers were procured, resulting in 157 transplants. In the NMP cohort, perfusion was commenced in all 40 cases and resulted in 34 transplants (use rates: 70% vs. 85% [p = 0.052], respectively). After PSM, 34 NMP liver recipients were matched with 68 NRP liver recipients. The two cohorts were similar for donor functional warm ischemia time (21 min after NRP vs. 20 min after NMP; p = 0.17), UK-Donation After Circulatory Death risk score (5 vs. 5 points; p = 0.38), and laboratory Model for End-Stage Liver Disease scores (12 vs. 12 points; p = 0.83). The incidence of nonanastomotic biliary strictures (1.5% vs. 2.9%; p &gt; 0.99), early allograft dysfunction (20.6% vs. 8.8%; p = 0.13), and 30-day graft loss (4.4% vs. 8.8%; p = 0.40) were similar, although peak posttransplant aspartate aminotransferase levels were higher in the NRP cohort (872 vs. 344 IU/L; p &lt; 0.001). NRP livers were more frequently allocated to recipients suffering from hepatocellular carcinoma (HCC; 60.3% vs. 20.6%; p &lt; 0.001). HCC-censored 2-year graft and patient survival rates were 91.5% versus 88.2% (p = 0.52) and 97.9% versus 94.1% (p = 0.25) after NRP and NMP, respectively. Both perfusion techniques achieved similar outcomes and appeared to match benchmarks expected for donation after brain death livers. This study may inform the design of a definitive trial.</abstract><pub>LIPPINCOTT WILLIAMS &amp; WILKINS</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1527-6465
ispartof LIVER TRANSPLANTATION, 2022-11, Vol.28 (11), p.1716-1725
issn 1527-6465
language eng
recordid cdi_kuleuven_dspace_20_500_12942_697692
source Lirias (KU Leuven Association); Access via Wiley Online Library; Alma/SFX Local Collection
title In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T20%3A42%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kuleuven&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20situ%20normothermic%20regional%20perfusion%20versus%20ex%20situ%20normothermic%20machine%20perfusion%20in%20liver%20transplantation%20from%20donation%20after%20circulatory%20death&rft.jtitle=LIVER%20TRANSPLANTATION&rft.au=Mohkam,%20Kayvan&rft.date=2022-11&rft.volume=28&rft.issue=11&rft.spage=1716&rft.epage=1725&rft.pages=1716-1725&rft.issn=1527-6465&rft_id=info:doi/&rft_dat=%3Ckuleuven%3E20_500_12942_697692%3C/kuleuven%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true